AusPAR: Ofatumumab

Australian Public Assessment Report

AusPAR

AusPAR: Ofatumumab [PDF, 706.81 KB]

AusPAR: Ofatumumab [Word, 660.67 KB]

Attachment: Extract from Clinical Evaluation Report: Ofatumumab [PDF, 8.81 MB]

Attachment: Extract from Clinical Evaluation Report: Ofatumumab [Word, 19.88 MB]

Device/Product Name

Arzerra

Active ingredients

Ofatumumab

AusPAR Date

12 January 2018

Published

25 January 2018

Submission Number

PM-2015-03290-1-4

Submission Type

Extension of indications

Decision

Withdrawn